Rein Therapeutics, Inc. business relationships
Companies named in Rein Therapeutics, Inc.’s 10-K filed 2026-03-26, and public companies whose annual reports name Rein Therapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.6 / 10
- AI naming
- 2 / 100 Top 9% in its category
- Agent readiness
- 20 / 100
- AI adoption
- 0 / 100
Layers: Peptides
Named in Rein Therapeutics, Inc.’s annual report 1
“...ficacy of LTI-03 measured through forced vital capacity, percent predicted FVC and high-resolution computer tomography, in collaboration with Qureight Ltd. Patients will undergo a 28-day screening period prior to being randomized and entering the 24-week treatment period, with a four-week follow-up.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.